AHPA Hemp-CBD Status Report

AHPA Hemp-CBD Status Report

Updated to cover recent FDA and USDA actions

Published: Tuesday, August 6, 2019

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

The revised Status Report: Marketing of hemp and cannabidiol (CBD) products in the United States following passage of the 2018 Farm Bill covers:

  • FDA actions on hemp-derived CBD in dietary supplements and foods, including recent public statements, hearings, enforcement policy and safety review.
  • FDA’s position on hemp-CBD in cosmetics as stated on its website Q&A.
  • USDA’s listening session to gather information and feedback from stakeholders as they develop regulations.
  • Details on USDA's Hemp Production Program to be administered under the Agricultural Marketing Service (AMS) have been posted on the USDA website.
  • USDA has issued a notice to trade regarding the importation of hemp seed.
  • USDA issued legal opinions regarding the implementation of some hemp provisions in the 2018 Farm Bill.

For the latest information on hemp and hemp-derived CBD in dietary supplements, register for AHPA's Hemp-CBD Supplement Congress being held August 15-16 in Denver, CO.

Order the updated Status Report here >>


2020 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.